Company: CDT
Filing Date: 2025-07-08
Form Type: DEF 14A
Source: 0001641172-25-018242
Chunk: 3

Company: CDT Equity Inc.
Filing Date: 2025-07-08
Form: DEF 14A
Chunk 3
---
 webcast of the meeting by registering in advance of the 2025 Annual Meeting at https://meeting.vstocktransfer.com/CONDUITAUG25. A Zoom account is required to register. If your shares are held by a bank, broker or other agent, please follow the instructions from your bank, broker or other agent to have your shares voted.

References in this proxy statement to the “Company,” “we,” “us,” “our” and similar terms mean Conduit Pharmaceuticals Inc.

The accompanying proxy is solicited by our Board of Directors (our “Board”) and is revocable by you at any time before it is voted at the 2025 Annual Meeting, as described below.

We intend to mail this Proxy Statement, the proxy card and the Notice of Annual Meeting on or about July 14, 2025 to all stockholders of record entitled to notice of and to vote at the Annual Meeting.

Our principal executive offices are located at 4581 Tamiami Trail North, Suite 200, Naples, FL 34103, and our telephone number is (646) 491-9132.

On January 25, 2025 and May 19, 2025, the Company effected a 1-for-100 reverse stock split and a 1-for-15 reverse stock split of its authorized shares of common stock, respectively (collectively the “Reverse Stock Splits”). The Reverse Stock Splits were accompanied by a corresponding decrease in the Company’s issued and outstanding shares of common stock. All references to numbers of shares of common stock and per-share information in this Proxy Statement have been adjusted retroactively, as appropriate, to reflect the Reverse Stock Splits, unless otherwise noted or the context suggests otherwise.

Who May Vote

Only holders of our common stock, par value $0.0001, (the “Common Stock”) outstanding as of the close of business on the Record Date are entitled to receive notice of, and to vote at, the 2025 Annual Meeting. As of the Record Date, there were 2,405,140 shares of Common Stock outstanding and entitled to vote at the 2025 Annual Meeting and there were no other classes of securities outstanding that will be entitled to vote at the 2025 Annual Meeting. Each share of Common Stock is entitled to one vote on all matters. There are no cumulative voting rights.

| 1 |

Voting Requirements and Quorum

At least one-third of the voting power of all outstanding shares of capital stock of the Company entitled to vote at